ASN: SGLT2 Inhibitor May Slow eGFR Decline in T2D (CME/CE)

(MedPage Today) -- Uniform treatment effect across entire distribution of renal function
Source: MedPage Today State Required CME - Category: Consumer Health News Source Type: news